Dow Jones aims for back-to-back record close after Fed pencils in 2024 rates cuts

0 1

U.S. stocks were pushing higher late Thursday, with the Dow Jones Industrial Average on pace for a back-to-back record close.

Optimism about the Federal Reserve’s interest-rate-cut projections delivered a day ago has been fueling a powerful rally, as benchmark borrowing costs drop.

How stocks are trading

  • The Dow Jones Industrial Average
    DJIA
    advanced 108 points, or 0.3%, to 37,201, after touching a record intraday high of 37,287.50.

  • The S&P 500
    SPX
    edged up 8 points, or 0.2%, to 4,715.

  • The Nasdaq Composite
    COMP
    rose 6 points, or less than 0.1%, to 14,742.

On Wednesday, the Dow rose 1.4% to a record close of 37,090, the S&P 500 increased 1.4% and the Nasdaq gained 1.4%.

What’s driving markets

U.S. stocks were adding to a powerful rally sparked a day ago when the Fed suggested interest rates have likely peaked in this cycle and penciled in 75 basis points of rate cuts in 2024.

“We’ve certainly rallied quite a bit in the last few days,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management, noting that a pause wouldn’t be a surprise.

While big equity gains were seen Wednesday after the Fed decision, the S&P 500, Dow and Nasdaq Composite each were advancing for seven straight sessions, leaving the S&P 500 less than 2% from its last record close nearly two years ago.

A major catalyst for stocks has been a retreating 10-year Treasury yield,
BX:TMUBMUSD10Y
which fell another 9 basis points to 3.93% on Thursday, after surging to 5% in October.

“I’m not at all concerned about the Santa Clause rally is going away,” Pavlik said.

The rally also appeared to be expanding beyond a small group of big-tech stocks. The Russell 200 index
RUT
of small-cap stocks was up 2.3% Thursday, after outperforming the big three equity indexes a day before.

Read: Russell 2000 on pace for best month versus S&P 500 in nearly 3 years

Sid Vaidya, U.S. wealth chief investment strategist at TD Wealth, said the big surprise from Wednesday was that Fed Chair Jerome Powell didn’t push back, as expected, on market expectations of rate cuts next year.

He also thinks optimism about rate cuts should be tempered, with the Fed indicating the first rate cut is likely to occur in the fall, while traders are expecting a pivot to cuts this spring.

“We are in between,” Vaidya said, offering a forecast for the first cut of the cycle to occur in the summer of 2024.

More global central bank decisions arrived early Thursday, with the Bank of England and European Central Bank leaving their interest rates unchanged at 5.25% and 4%, respectively.

The ECB also signaled it would halt its last remaining bond-buying scheme — the €1.7 trillion ($1.9 trillion) Pandemic Emergency Purchase Program — earlier than expected, in mid-2024.

In U.S. economic Thursday, initial jobless claims fell by 19,000 to 202,000 in the week ending Dec. 9, the lowest level since mid-October. Data also showed sales at U.S. retailers rose a solid 0.3% in November in a good start to the holiday shopping season, suggesting the economy might not be cooling off all that much.

Mortgage rates also were falling, with the 30-year fixed rate pegged below 7% for the first time since August.

Thursday’s earnings include reports from retailer Costco
COST,
-1.75%
and homebuilder Lennar
LEN,
+6.69%,
which will release results after the closing bell.

See: Dow scores its highest close in history. Here’s what that means in the big picture.

Companies in focus

  • Walt Disney Co. shares
    DIS,
    +1.20%
    were up Thursday after activist investor Nelson Peltz said he intends to nominate himself and former Walt Disney Co. Chief Financial Officer Jay Rasulo to Disney’s board.

  • Intel Corp. shares
    INTC,
    +1.37%
    climbed after the company announced new PC chips Thursday that can power many computers built for artificial-intelligence tasks.

  • French media conglomerate Vivendi
    VIV,
    +9.96%
    said it is exploring plans to split itself into three separate listed companies, causing its share price to surge. 

  • Moderna Inc.’s stock
    MRNA,
    +9.25%
    soared after the biotech company and partner Merck & Co.
    MRK,
    -0.39%
    announced positive data from a midstage trial of Moderna’s mRNA-4157 in combination with Merck’s blockbuster cancer drug Keytruda.

  • Occidental Petroleum shares
    OXY,
    +2.71%
    rose after Warren Buffett’s Berkshire Hathaway increased its stake in the company.

Jamie Chisholm contributed.

Read the full article here

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy